These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 30120496

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A new grading system for ototoxicity in adults.
    Theunissen EA, Dreschler WA, Latenstein MN, Rasch CR, van der Baan S, de Boer JP, Balm AJ, Zuur CL.
    Ann Otol Rhinol Laryngol; 2014 Oct; 123(10):711-8. PubMed ID: 24820112
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Feasibility and acute toxicity of Concurrent Chemoradiotherapy (CCRT) with high-dose rate intracavitary brachytherapy (HDR-ICBT) and 40-mg/m2 weekly cisplatin for Japanese patients with cervical cancer: results of a Multi-Institutional Phase 2 Study (JGOG1066).
    Toita T, Kitagawa R, Hamano T, Umayahara K, Hirashima Y, Aoki Y, Oguchi M, Mikami M, Takizawa K, Cervical Cancer Vulva Cancer Committee of the Japanese Gynecologic Oncology Group.
    Int J Gynecol Cancer; 2012 Oct; 22(8):1420-6. PubMed ID: 22932262
    [Abstract] [Full Text] [Related]

  • 9. [Monitoring hearing during ototoxic cisplatin therapy].
    Kluba J, Kluba U, von Specht H, Mittler U.
    Padiatr Grenzgeb; 1990 Oct; 29(1):19-23. PubMed ID: 2342815
    [Abstract] [Full Text] [Related]

  • 10. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
    Das N, Kaushal D, Patro SK, Pareek P, Dixit A, Soni K, Prakasan Nair N, Choudhury B, Goyal A.
    Acta Otolaryngol; 2021 Sep; 141(9):885-893. PubMed ID: 34486907
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hearing loss due to concurrent daily low-dose cisplatin chemoradiation for locally advanced head and neck cancer.
    Zuur CL, Simis YJ, Verkaik RS, Schornagel JH, Balm AJ, Dreschler WA, Rasch CR.
    Radiother Oncol; 2008 Oct; 89(1):38-43. PubMed ID: 18706728
    [Abstract] [Full Text] [Related]

  • 14. Long-term ototoxicity in women after cisplatin treatment for ovarian germ cell cancer.
    Skalleberg J, Solheim O, Fosså SD, Småstuen MC, Osnes T, Gundersen POM, Bunne M.
    Gynecol Oncol; 2017 Apr; 145(1):148-153. PubMed ID: 28202195
    [Abstract] [Full Text] [Related]

  • 15. Platinum compound-related ototoxicity in children: long-term follow-up reveals continuous worsening of hearing loss.
    Bertolini P, Lassalle M, Mercier G, Raquin MA, Izzi G, Corradini N, Hartmann O.
    J Pediatr Hematol Oncol; 2004 Oct; 26(10):649-55. PubMed ID: 15454836
    [Abstract] [Full Text] [Related]

  • 16. Chemoradiation-induced hearing loss remains a major concern for head and neck cancer patients.
    Schmitt NC, Page BR.
    Int J Audiol; 2018 Sep; 57(sup4):S49-S54. PubMed ID: 28728452
    [Abstract] [Full Text] [Related]

  • 17. Sensorineural hearing loss following induction chemotherapy plus concurrent chemoradiotherapy for advanced nasopharyngeal carcinoma.
    Atchariyasathian V, Pruegsanusak K, Wongsriwattanakul S.
    J Laryngol Otol; 2015 Aug; 129(8):767-72. PubMed ID: 26112091
    [Abstract] [Full Text] [Related]

  • 18. Auditory function and quality of life in patients receiving cisplatin chemotherapy in head and neck cancer: A case series follow-up study.
    Kalyanam B, Sarala N, Azeem Mohiyuddin SM, Diwakar R.
    J Cancer Res Ther; 2018 Aug; 14(5):1099-1104. PubMed ID: 30197356
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Hearing assessment of children treated with Cisplatin].
    Mniszek J, Bielecki I, Sobol G.
    Pol Merkur Lekarski; 2009 Aug; 27(158):105-8. PubMed ID: 19856874
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.